Financhill
Back

Repligen Stock Predictions

Repligen Stock Forecast

  • Over the next 52 weeks, Repligen has on average historically risen by 23.7% based on the past 38 years of stock performance.
  • Repligen has risen higher in 19 of those 38 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Repligen Stock Undervalued?
    The current Repligen [RGEN] share price is $139.99. The Score for RGEN is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • RGEN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Repligen Stock Go Up Next Year?

  • Over the next 52 weeks, Repligen has on average historically risen by 23.7% based on the past 38 years of stock performance.

Repligen Stock Rating

Sell
26
Repligen (RGEN) is a Sell

Is Repligen overpriced?

  • Repligen has risen higher in 19 of those 38 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Repligen Stock Price History

Is RGEN stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGEN is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Life Sciences Tools & Services
Sector:
Health Care
Type:
stock
Website:
repligen.com

52-Week Data

52-Week High:
200.03
52-Week Low:
113.50

Prediction Charts

Market Cap:
7.9B
Price in USD:
139.99
Volume:
619.9K
Beta:
0.98

Technical Analysis

SMA50:
156.35
SMA100:
150.33
SMA200:
145.80
52-Wk Change:
-29.91%

Stock Predictions

  • Is Repligen stock public?
    Yes, Repligen is a publicly traded company.
  • What is the Repligen stock quote today?
    The Repligen stock price is 139.99 USD today.
  • How to buy Repligen stock online?
    You can buy Repligen shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-3 159.44 155.38 160.99 153.81
Mar-4 153.62 155.15 156.82 147.37
Mar-5 154.53 157.80 160.00 152.25
Mar-6 155.97 160.11 163.78 155.35
Mar-7 159.63 155.82 161.68 149.88
Mar-11 138.54 147.13 148.54 137.56
Mar-12 148.52 145.37 149.66 141.26
Mar-13 145.18 142.44 146.65 140.93
Mar-14 143.92 150.62 150.87 142.79
Mar-17 150.42 152.81 153.89 147.99
Mar-18 144.61 144.34 147.61 139.07
Mar-19 144.12 144.88 146.60 138.01
Mar-20 140.65 139.34 144.33 137.92
Mar-21 136.61 139.99 140.39 135.71

Repligen Earnings

Repligen Earnings Report: Per Share Repligen Earnings Q1 Q2 Q3 and Q4 last year and next year.

Repligen Forecast Revenue Growth

Repligen Stock Analysis: Historical quarterly revenues per share for Repligen and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.09 per share, an increase next quarter of $0.06 per share, an increase this year of $0.18 per share, and an increase next year of $0.47 per share.

* Repligen stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.